Linda Bain Codiak Bio Sciences, Inc. (CDAK) insider trading activity

Linda Bain is Chief Financial Officer of Codiak BioSciences, Inc.. Currently has a direct ownership of 0 shares of CDAK, which is worth approximately $0. The most recent transaction as insider was on Mar 28, 2023, when has been sold 13,412 shares (Common Stock) at a price of $0.17 per share, resulting in proceeds of $2,280. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Linda Bain Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 28 2023	SELL Open market or private sale	$2,280 $0.17 p/Share	13,412 Reduced 100.0%	0 Common Stock
Feb 17 2023	SELL Open market or private sale	$1,516 $0.59 p/Share	2,570 Reduced 16.08%	13,412 Common Stock
Feb 16 2023	BUY Exercise of conversion of derivative security	-	7,613 Added 32.27%	15,982 Common Stock
Jan 20 2023	SELL Open market or private sale	$1,071 $0.57 p/Share	1,880 Reduced 37.6%	3,120 Common Stock
Jan 19 2023	BUY Exercise of conversion of derivative security	-	5,000 Added 50.0%	5,000 Common Stock
Aug 17 2022	SELL Open market or private sale	$5,224 $2.21 p/Share	2,364 Reduced 22.03%	8,369 Common Stock
Aug 16 2022	BUY Exercise of conversion of derivative security	-	7,613 Added 41.5%	10,733 Common Stock

Also insider at

ARVN

ARVINAS, INC. Healthcare

Director

VBIV

VBI Vaccines Inc Healthcare

Director

Linda Bain

Chief Financial Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDAK shares.

Notify only if

Value

Insider Trading

Get notified when an Codiak Bio Sciences, Inc. insider buys or sells CDAK shares.

Notify only if

Operation

Value

Type

News

Receive news related to Codiak BioSciences, Inc.

Track Activities on CDAK

Account